Loading the section…

AXGN: financial statements from SEC — TradeAlmanac

AXGN

Axogen, Inc.: financial statements

Company reports as filed with the U.S. Securities and Exchange Commission.

AnnualQuarterly

Income statement

Metric	31/03/2026	30/09/2025	30/06/2025	31/03/2025	30/09/2024	30/06/2024
Revenue	61M	60M	57M	49M	49M	48M
Cost of revenue	15M	14M	15M	14M	12M	13M
Gross profit	46M	46M	42M	35M	36M	35M
Research and development	8M	8M	7M	6M	7M	7M
Selling, general and administrative	13M	11M	10M	9M	11M	9M
Operating expenses	49M	44M	40M	37M	37M	36M
Operating income	−3M	2M	2M	−2M	−316,000	−428,000
Net income	−20M	708,000	579,000	−4M	−2M	−2M
Earnings per share	−0.38	0.02	0.01	−0.08	−0.04	−0.04
Earnings per share, diluted	−0.38	0.01	0.01	−0.08	−0.04	−0.04
Weighted average shares	52M	46M	46M	45M	44M	44M
Weighted average shares, diluted	52M	49M	48M	45M	44M	44M

Balance sheet

Metric	31/03/2026	31/12/2025	30/09/2025	30/06/2025	31/03/2025	31/12/2024	30/09/2024	30/06/2024
Cash and equivalents	83M	36M	24M	20M	18M	28M	25M	25M
Short-term investments	19M	6M	12M

Cash flow

Metric	31/03/2026	31/03/2025
Operating cash flow	2M	−13M
Depreciation and amortisation	2M	2M
Share-based compensation	7M	3M
Capital expenditure	3M	256,000
Investing cash flow	−16M	1M
Financing cash flow	60M

Amounts in USD unless stated otherwise. Data: US exchange trading and company filings with the regulator